Table 3

Crystal analytic study (CCA, Raman spectroscopy, elemental bioanalysis, metabolomic, mass spectrometry) characteristics and features

StudyModalityDiagnosis of CPPDPublication datePatients (N)Features examinedPrevalence of pattern by siteSensitivitySpecificity
Pollet et al22CCACPPD crystal analysis5/2015180Synovial fluid crystal analysisND66.7%93.2%
Robier et al23CCACPPD crystal analysis6/201450Synovial CCP crystal count with cytospin and smearCytospin 96/10HPF, smear 2.5/10HPFNDND
Tausche et al24CCACPPD crystal analysis8/201375CCP crystals/field day 0 and stored for 1–3 days>5/field 33.3%,
<5/field 66.6%
NDND
Cheng et al25Raman spectroscopyCPPD crystal analysis4/200935CCP crystal analysis with Raman and PLMAgreement 91.4%, discrepancy 8.5%,
confirmation 100% correct with Raman, 33.3% correct with PLM
NDND
Li et al26Raman spectroscopyCPPD crystal analysis2/2014NDCPPD crystals concentrations detected by CARD and PLMCARD 1 ug/mL,
PLM 10–100 ug/mL
NDND
Fuerst et al27Raman spectroscopyCPPD crystal analysis3/20104CPPD crystal analysis by Raman spectraCPPD 25%, HA 75%NDND
Li et al28Raman spectroscopyCPPD crystal analysis2/2016174Rapid POCR compared with CPLM for CPPD and gout diagnosesOverall 89.7% POCR and CPLM agreement;
κ coefficient for POCR and CPLM: 0.61 (95% CI 0.42 to 0.81) in CPPD; 0.84 (CI 0.75 to 0.94) in gout
NDND
Nguyen et al29Elemental bioanalysisCPPD crystal analysis201320 (141 cartilage samples)CaC crystals and CPP crystals in patients with OA by FT-IRCaC crystals 68.3%, CPP crystals 14.1%NDND
Hugle et al30MetabolomicCPPD crystal analysis3/201259Metabolomic profiling of knee synovial fluid with NMR35 different metabolites identified, no difference compared with OANDND
Austin et al31Mass spectrometryCPPD crystal analysis3/2009NDCPP crystal identification with LA ICP-MSHigh calcium, phosphorus, magnesium, strontium intensities in cartilage and synthetic synovial fluidNDND
  • CaC, calcium-containing; CARD, cost-efficient automated Raman device; CCA, conventional crystal analysis; CCP, cyclic citrullinated peptide; CPLM, compensated polarised light microscopy; CPPD, calcium pyrophosphate crystal deposition disease; FT-IR, Fourier-transform infrared spectroscopy; HA, hydroxyapatite; LA ICP-MS, laser ablation inductively coupled plasma mass spectrometry; ND, not defined; NMR, nuclear MR; OA, osteoarthritis; PLM, polarised light microscopy; POCR, point of care Raman.